• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SenesTech's Evolve™ Rodent Birth Control Proven in Urban Rodent Hotspots from Hong Kong to San Francisco

    6/26/25 8:00:00 AM ET
    $SNES
    Agricultural Chemicals
    Industrials
    Get the next $SNES alert in real time by email

    Pallet and Container Orders Expected for Resupply and Expansion

    SURPRISE, Ariz., June 26, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES, ", SenesTech", or the ", Company", )), a leader in fertility control for managing animal pest populations, today announced compelling results from two major urban deployments — one in Hong Kong and one in San Francisco — showing how pairing Evolve™ Rat Birth Control with traditional poison bait stations delivers faster, more sustainable rodent control where it's needed most.

    SenesTech, Inc. is a pioneer in fertility control solutions for managing rodent populations. (PRNewsfoto/SenesTech, Inc.)

    Global Cities Face Persistent Rodent Pressure

    Urban centers worldwide face constant rodent challenges due to dense infrastructure, hard-to-access breeding sites, and abundant food sources. Even the most aggressive traditional rodenticide programs often fall short over time, as rodents adapt to poisons and continue to reproduce unchecked.

    A Breakthrough: Combining Fertility Control with Traditional Rodenticides

    In both Hong Kong and San Francisco, pest management teams implemented a novel integrated strategy: deploying Evolve's palatable soft bait alongside conventional rodenticide blocks within standard bait stations across infested buildings and surrounding areas.

    This hybrid approach tackles two critical issues simultaneously:

    • Immediate population knockdown via targeted poison baiting
    • Long-term population suppression by disrupting rodent reproduction cycles with fertility control

    In Hong Kong, this method was applied in a high-density mixed-use building with persistent rodent activity. Within three months, sightings fell dramatically, bait consumption declined as the population shrank, and no new litters were detected — breaking the cycle of reinfestation that had frustrated property managers for years.

    Further details on this study can be read here.

    In San Francisco, an urban deployment in a heavily trafficked neighborhood known for recurring infestations achieved similar success: a clear reduction in visible rodent activity, less poison used overall, and a measurable drop in new rodent births.

    A New Industry Standard for Sustainable Urban IPM

    "These successes prove that fertility control isn't just an idea — it's a practical tool that helps pest professionals get ahead of chronic infestations faster and with less rodenticide. Deploying Evolve alongside bait blocks strengthens any IPM program. Cities worldwide can benefit from this smarter, more sustainable approach," said Joel Fruendt, CEO of SenesTech. "These kinds of validating results are also what trigger rapid expansion – we are currently preparing for a container-sized order from Hong Kong, for example."

    Delivering Value to Investors and Operators

    Fertility control solutions like Evolve align with changing environmental regulations and public demand for humane, low-toxicity pest management. For pest control professionals and property owners, this means improved outcomes, new service offerings, and better ROI from each deployment. For investors, it signals a rapidly growing global market for next-generation rodent control solutions that complement and enhance traditional tools.

    About SenesTech

    We are committed to improving the health of the world by humanely managing animal pest populations through our expertise in fertility control. We invented ContraPest®, the only U.S. EPA-registered contraceptive for male and female rats, as well as Evolve™ Rat and Evolve™ Mouse, EPA-designated minimum risk contraceptives for rodents, reflecting our mission to provide products that are proactive, safe and sustainable. ContraPest and Evolve fit seamlessly into all integrated pest management programs, significantly improving the overall goal of effective pest management. We strive for clean cities, efficient businesses and happy households – with a product designed to be humane, effective and sustainable.

    For more information visit https://senestech.com/.

    Safe Harbor Statement

    This press release contains "forward-looking statements" within the meaning of federal securities laws, and we intend that such forward-looking statements be subject to the safe harbor created thereby. Such forward-looking statements include, among others, our belief that pairing Evolve with traditional poison bait stations delivers faster, more sustainable rodent control where it's needed most; our belief that fertility control is a practical tool that helps pest professionals get ahead of chronic infestations faster and with less rodenticide; our belief that deploying Evolve alongside bait blocks strengthens any IPM program; our belief that cities worldwide can benefit from this smarter, more sustainable approach; our belief that fertility control solutions like Evolve align with changing environmental regulations and public demand for humane, low-toxicity pest management, meaning improved outcomes, new service offerings, and better ROI from each deployment for pest control professionals and property owners, and signaling to investors a rapidly growing global market for next-generation rodent control solutions that complement and enhance traditional tools. Forward-looking statements may describe future expectations, plans, results or strategies and are often, but not always, made through the use of words such as "believe," "may," "future," "plan," "will," "should," "expect," "anticipate," "eventually," "project," "estimate," "continuing," "intend" and similar words or phrases. You are cautioned that such statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those reflected by such forward-looking statements. Such factors include, among others, the successful commercialization of our products, market acceptance of our products, regulatory approval and regulation of our products and other factors and risks identified from time to time in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2024. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management's assumptions and estimates as of such date. Except as required by law, we do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise.

    Contact Information:

    Investors:

    Robert Blum, Lytham Partners, LLC

    (602) 889-9700

    [email protected]

    Marketing:

    Rochelle Paulet, Director of Marketing, SenesTech, Inc.

    (928) 779-4143 x814

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/senestechs-evolve-rodent-birth-control-proven-in-urban-rodent-hotspots-from-hong-kong-to-san-francisco-302491716.html

    SOURCE SenesTech, Inc.

    Get the next $SNES alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SNES

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $SNES
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    SenesTech Strengthens Direct-to-Consumer Commercial Strategy by Directly Managing Amazon Sales of Evolve™ Rat and Evolve™ Mouse

    Transition from Third-Party to Internal Management Expected to Increase Revenue and Enhance Margin on E-Commerce Channel Moving Forward While Building on Early Success PHOENIX, Feb. 10, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES) today announced that it will begin directly managing sales of its Evolve™ Rat and Evolve™ Mouse products on Amazon. The change reflects the Company's continued focus on e-commerce as an important distribution channel and will be effective immediately. In 2025, e-commerce represented over 50% of SenesTech's revenue, with about one half of that d

    2/10/26 8:00:00 AM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SenesTech's Evolve® Approved in New Zealand

    Supporting New Zealand's Predator Free 2050 Initiative Initial Stocking Order Fulfilled PHOENIX, Feb. 2, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), a pioneer in fertility control solutions for managing rodent populations, is pleased to announce that Evolve® has been approved for use in New Zealand by the Ministry for Primary Industries. SenesTech's exclusive distribution partner, Evicom, has been shipped its initial stocking order. Rodent overpopulation remains a major ecological and economic challenge in New Zealand, threatening native wildlife, agriculture, and urba

    2/2/26 8:00:00 AM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SenesTech Announces CEO Transition Plan

    Board To Initiate Search For New Leadership As Current CEO Plans Retirement Dr. Jamie Bechtel Named Interim Executive Chair To Further Support Transition PHOENIX, Jan. 28, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), a pioneer in fertility control solutions for managing rodent populations, today announced that Joel Fruendt, President and Chief Executive Officer, has informed the Board of Directors of his intent to retire. The Board will commence a formal search for a successor. Mr. Fruendt will continue to serve as President and CEO until the search is completed or until June 30, 2026, whichever occurs first.

    1/28/26 4:05:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $SNES
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Glenbrook Capital Management bought $56,667 worth of shares (31,346 units at $1.81) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    2/13/26 5:20:17 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Large owner Glenbrook Capital Management bought $15,480 worth of shares (8,569 units at $1.81) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    2/6/26 5:40:20 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Large owner Glenbrook Capital Management bought $94,524 worth of shares (48,138 units at $1.96) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    2/3/26 5:27:37 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $SNES
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Glenbrook Capital Management bought $56,667 worth of shares (31,346 units at $1.81) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    2/13/26 5:20:17 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Large owner Glenbrook Capital Management bought $15,480 worth of shares (8,569 units at $1.81) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    2/6/26 5:40:20 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Large owner Glenbrook Capital Management bought $94,524 worth of shares (48,138 units at $1.96) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    2/3/26 5:27:37 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $SNES
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by SenesTech Inc.

    SCHEDULE 13G/A - SenesTech, Inc. (0001680378) (Subject)

    2/2/26 5:26:13 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Amendment: SenesTech Inc. filed SEC Form 8-K: Leadership Update

    8-K/A - SenesTech, Inc. (0001680378) (Filer)

    1/28/26 5:26:33 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SenesTech Inc. filed SEC Form 8-K: Leadership Update

    8-K - SenesTech, Inc. (0001680378) (Filer)

    1/28/26 4:01:46 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $SNES
    Leadership Updates

    Live Leadership Updates

    View All

    SenesTech Announces CEO Transition Plan

    Board To Initiate Search For New Leadership As Current CEO Plans Retirement Dr. Jamie Bechtel Named Interim Executive Chair To Further Support Transition PHOENIX, Jan. 28, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), a pioneer in fertility control solutions for managing rodent populations, today announced that Joel Fruendt, President and Chief Executive Officer, has informed the Board of Directors of his intent to retire. The Board will commence a formal search for a successor. Mr. Fruendt will continue to serve as President and CEO until the search is completed or until June 30, 2026, whichever occurs first.

    1/28/26 4:05:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SenesTech Names Nicole Williams as Chief Revenue Officer

    PHOENIX, Feb. 16, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES, ", SenesTech", or the ", Company", ))), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today reported the appointment of Nicole Williams as Chief Revenue Officer. Ms. Williams was previously Chief Strategy Officer, and this appointment is part of an expansion and restructuring of the sales organization and commercialization efforts. The restructuring of the team comes after yet another quarter and fiscal ye

    2/16/23 9:00:00 AM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SenesTech Announces Appointment of Vector and Pest Control Industry Veteran Joel Fruendt as Chief Executive Officer

    PHOENIX, Nov. 14, 2022 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES, ", SenesTech", or the ", Company", ))), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today announced the appointment of Joel Fruendt as SenesTech's new Chief Executive Officer, succeeding Ken Siegel. Mr. Siegel, who is expected to retire at the end of the year, will remain as an Executive Director, in a consultative role, through the transition period. This leadership transition is part of SenesTech's ongoing strategic plan to drive the commercialization of ContraPest, its flagship product.

    11/14/22 9:10:00 AM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $SNES
    Financials

    Live finance-specific insights

    View All

    SenesTech Reports Third Quarter 2025 Financial Results with Record Revenue and Adjusted EBITDA

    77% Revenue Growth in Evolve® Rodent Birth Control™ Products Strong Cash Balance and Progress Toward Profitability SURPRISE, Ariz., Nov. 10, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), the leader in fertility control for managing animal pest populations and the only manufacturer of EPA-compliant Rodent Birth Control™ products today announced its financial results for the third quarter ended September 30, 2025. Q3 2025 Financial Highlights Revenues increased by 43% to $690,000, a record for the Company, from $482,000 in Q3 2024.Evolve® Rodent Birth Control product sales

    11/10/25 4:05:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SenesTech to Report Third Quarter 2025 Financial Results on Monday, November 10, 2025

    Financial results to be released after market close; Conference call to be conducted at 5:00 p.m. Eastern time PHOENIX, Nov. 3, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), the leader in fertility control for pest management, will report third quarter 2025 financial results for the period ended September 30, 2025, after the market close on Monday, November 10, 2025. The Company has scheduled a conference call that same day, Monday, November 10, 2025, at 5:00 p.m. Eastern time, to review the results. Third Quarter 2025 Conference Call Details Date and Time: Monday, Novem

    11/3/25 4:15:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SenesTech Reports Second Quarter 2025 Financial Results with Record Revenue and Record Gross Profit Margins

    94% Revenue Growth in Evolve™ Rodent Birth Control Products Strong Cash Balance and Sustained Progress Toward Profitability SURPRISE, Ariz., Aug. 7, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), the leader in fertility control for managing animal pest populations and the only manufacturer of EPA-registered rodent birth control products today announced its financial results for the second quarter ended June 30, 2025. Q2 2025 Highlights Revenues increased 36% to $625,000, a record for the Company, from $459,000 in Q2 2024.Evolve Rodent Birth Control products sales grew 94%

    8/7/25 4:05:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $SNES
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by SenesTech Inc.

    SC 13G/A - SenesTech, Inc. (0001680378) (Subject)

    11/14/24 7:28:08 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Amendment: SEC Form SC 13G/A filed by SenesTech Inc.

    SC 13G/A - SenesTech, Inc. (0001680378) (Subject)

    11/14/24 7:12:23 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SEC Form SC 13G filed by SenesTech Inc.

    SC 13G - SenesTech, Inc. (0001680378) (Subject)

    11/12/24 4:30:48 PM ET
    $SNES
    Agricultural Chemicals
    Industrials